The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus
Open accessAbstract
Autoantibodies against nucleic acids and excessive type I interferon (IFN) are hallmarks of human systemic lupus erythematosus (SLE). We previously reported that SLE neutrophils exposed to TLR7 agonist autoantibodies release interferogenic DNA, which we now demonstrate to be of mitochondrial origin. We further show that healthy human neutrophils do not complete mitophagy upon induction of mitochondrial damage. Rather, they extrude mitochondrial components, including DNA (mtDNA), devoid of oxidized (Ox) residues. When mtDNA undergoes oxidation, it is directly routed to lysosomes for degradation. This rerouting requires dissociation from the transcription factor A mitochondria (TFAM), a dual high-mobility group (HMG) protein involved in maintenance and compaction of the mitochondrial genome into nucleoids. Exposure of SLE neutrophils, or healthy IFN-primed neutrophils, to antiribonucleotide protein autoantibodies blocks TFAM phosphorylation, a necessary step for nucleoid dissociation. Consequently, Ox nucleoids accumulate within mitochondria and are eventually extruded as potent interferogenic complexes. In support of the in vivo relevance of this phenomenon, mitochondrial retention of Ox nucleoids is a feature of SLE blood neutrophils, and autoantibodies against Ox mtDNA are present in a fraction of patients. This pathway represents a novel therapeutic target in human SLE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Different cellular lineages (10–18) may extrude their mitochondria upon activation.”
From Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA (2019) · cites this paper as [12]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Extracellular mitochondria have been identified in damaged tissues (8, 18–20); diverse inflammatory conditions (11, 12, 14, 21–24); and in the blood of critical care patients (22).”
From Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA (2019) · cites this paper as [12]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Various cellular lineages are capable of extruding their mitochondria. Activated mast cells10, T-cells11, eosinophils12, hepatocytes13, neutrophils14–16 and platelets17,18, in addition to damaged organs or tissues7,13,19,20, release extracellular mitochondria.”
From Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations (2019) · cites this paper as [16]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Extracellular mitochondria have been described in various clinical conditions, including trauma25,26, burn injury27, cancer28, rheumatoid arthritis17,29, systemic lupus erythematosus (SLE)15,16 and transfusion adverse reactions17,18,30,31.”
From Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations (2019) · cites this paper as [16]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several reports demonstrate that a considerable fraction of the nucleic acids contained in NETs is of mitochondrial, rather than nuclear, origin [724–728].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [727]
Experimental — accuracy not yet measured
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812 · cited 2×
“mtDNA activates neutrophils through TLR9 engagement (Zhang et al., 2010) and, upon cytoplasmic leakage, leads to cell autonomous NLRP3 and TLR9 activation (Nakahira et al.”
BackgroundAntimicrobial Autophagy: A Conserved Innate Immune Response in Drosophila
Moy, R. H., & Cherry, S. (2013) · Journal of Innate Immunity · doi:10.1159/000350326 · Cited by 3,539
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049 · cited 2×
“, 2010) and, upon cytoplasmic leakage, leads to cell autonomous NLRP3 and TLR9 activation (Nakahira et al., 2011; Oka et al., 2012).”
BackgroundOxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis
Shimada, K., Crother, T. R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S., Ramanujan, V. K., Wolf, A. J., Vergnes, L., Ojcius, D. M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.009 · Cited by 2,282 · cited 1×
“3 A, bottom). mtDNA is highly susceptible to oxidation (Yakes and Van Houten, 1997), a proinflammatory modification (Shimada et al., 2012).”
BackgroundInterferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,958 · cited 1×
“Expression of IFN- and neutrophil-related transcripts correlates with disease activity, and common allelic gene variants within these pathways confer disease susceptibility (Bennett et al., 2003; Moser et al., 2009; Bentham et al., 2015).”
BackgroundSelf-citationPlasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910 · cited 2×
“Addition of the cationic peptide LL-37 to facilitate their uptake (Lande et al., 2007) resulted in a 10fold increase in IFN-α levels in the presence of Ox mtDNA (Fig.”
BackgroundThe pathways of mitophagy for quality control and clearance of mitochondria
Ashrafi, G., & Schwarz, T. L. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.81 · Cited by 1,900 · cited 1×
“This process requires autophagy activation, sequestration of damaged mitochondria into autophagosomes, and fusion of autophagosomes with lysosomes (Ashrafi and Schwarz, 2013).”
BackgroundYakes, F. M., & Van Houten, B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.514 · Cited by 1,854
Garcia-Romo, G. S., Caielli, S., Vega, B., Connolly, J., Allantaz, F., Xu, Z., Punaro, M., Baisch, J., Guiducci, C., Coffman, R. L., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001201 · Cited by 1,383 · cited 11×
“5 DIS CUS SION SLE neutrophils extrude interferogenic DNA when activated with anti-Sm/RNP antibodies in an FcγR, TLR7, and ROS-dependent manner (Garcia-Romo et al., 2011).”
BackgroundMethodInfluentialSelf-citation
Cited by
Items 301–400 of 502
Fan, X., Ng, C. T., Guo, D., Lim, F. T. W., Tan, J. C., Law, A. H. N., Goh, L. H., Poon, Z. Y., Cheung, A. M. S., Kong, S. L., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42383 · Cited by 19
Current Challenges and Limitations in Antibody-Based Detection of Citrullinated Histones
Neeli, I., & Radic, M. Z. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00528 · Cited by 20
Ahmed, A., Li, S., Yu, J. J., & Shao, W.-H. (2025) · Pathophysiology · doi:10.3390/pathophysiology32040061 · Cited by 25
“Mechanisms such as mitochondrial stress, damage, or defective clearance likely expose these antigens, with neutrophils serving as a significant source of mitochondrial components extracellularly [146].”
Mitochondrial transplantation and transfer: The promising method for diseases
Kubat, G. B. (2023) · TURKISH JOURNAL OF BIOLOGY · doi:10.55730/1300-0152.2665 · Cited by 17
“The contents of the mitochondria, including oxidized mitochondrial nucleoids, can be extruded by neutrophils (Caielli et al., 2016).”
BackgroundNADPH oxidase in B cells and macrophages protects against murine lupus by regulation of TLR7
Gordon, R. A., Cosgrove, H. A., Marinov, A. D., Gingras, S., Tilstra, J. S., Campbell, A. M., Bastacky, S., Kashgarian, M. J., Perl, A., Nickerson, K. M., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.178563 · Cited by 20
“NETs were postulated to be a major source of autoantigen and were thought to consequently drive disease in SLE (74–83).”
BackgroundDevelopment and Functions of Mitochondria in Early Life
Maheshwari, A., Peng, J., Ramatchandirin, B., Pearah, A., & He, L. (2022) · Newborn · doi:10.5005/jp-journals-11002-0013 · Cited by 20
Lee, A. M., Laurent, P., Nathan, C., & Barrat, F. J. (2023) · European Journal of Immunology · doi:10.1002/eji.202350666 · Cited by 16
General Features of Autoimmune Disease
Davidson, A., & Diamond, B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00003-8 · Cited by 22
Abnormal Mitochondrial Physiology in the Pathogenesis of Systemic Lupus Erythematosus
Wincup, C., & Radziszewska, A. (2021) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2021.05.001 · Cited by 15
Peng, S., Stojkov, D., Gao, J., Oberson, K., Latzin, P., Casaulta, C., Yousefi, S., & Simon, H.-U. (2022) · PLOS Biology · doi:10.1371/journal.pbio.3001794 · Cited by 15
Li, H., Zhou, L., Zhou, W., Zhang, X., Shang, J., Feng, X., Yu, L., Fan, J., Ren, J., Zhang, R., et al. (2024) · Rheumatology & autoimmunity · doi:10.1002/rai2.12119 · Cited by 15
Abnormal energy metabolism in the pathogenesis of systemic lupus erythematosus
Cao, S., Jiang, J., Yin, H., Wang, L., & Lu, Q. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112149 · Cited by 19
Whole blood mitochondrial DNA copy number in depression and response to electroconvulsive therapy
Ryan, K. M., Doody, E., & McLoughlin, D. M. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110656 · Cited by 22
Burning controversies in NETs and autoimmunity: The mysteries of cell death and autoimmune disease
Dwivedi, N., & Radic, M. Z. (2018) · Autoimmunity · doi:10.1080/08916934.2018.1523395 · Cited by 21
“This may be a result of incomplete mitophagy of mitochondria with damaged membranes [114].”
BackgroundThe cGAS-STING axis: a comprehensive review from immune defense to disease pathogenesis
Sood, A. (2025) · Immunologic Research · doi:10.1007/s12026-025-09648-z · Cited by 20
“Loss of function mutations in TREX1, RNaseH2C, and DNase1 lead to cytosolic DNA accumulation, further triggering the cGAS-STING pathway to produce type I interferons [146–148].”
Dragoni, F., Garau, J., Sproviero, D., Orcesi, S., Varesio, C., Siervi, S. D., Gagliardi, S., Cereda, C., & Pansarasa, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214482 · Cited by 14
“which are the substrate of ROS oxidation [21].”
BackgroundThe critical roles of STING in mitochondrial homeostasis
Zou, S., Wang, B., Yi, K., Su, D., Chen, Y., Li, N., & Geng, Q. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115938 · Cited by 17
The role of NETosis in the pathogenesis of immunoinflammatory rheumatic diseases
Nasonov, E. L., Avdeeva, A. S., Reshetnyak, T. M., Aleksankin, A. P., & Rubtsov, Y. P. (2023) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2023-513-530 · Cited by 15
“Аутоантитела (АНА) ± ИФН-α [33–35] • Источник аутоантигенов [37–39] • Активация пДК: синтез ИФН-α [34, 40–42] • Активация макрофагов [43, 44]: усиление инфлюкса кальция [44], синтез ИЛ-6 и ФНО-α [44], ИЛ-1 и ИЛ-8 [43] • Активация В-клеток [45] • Активация комплемента [38] • Ослабление…”
Rösing, S., Ullrich, F., Meisterfeld, S., Schmidt, F., Mlitzko, L., Croon, M., Nattrass, R. G., Eberl, N., Mahlberg, J., Schlee, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45535-1 · Cited by 19
“The release of mtDNA has also been found to drive a growing number of other degenerative and autoin fl ammatory diseases via the cGAS/STING axis 63 including Parkinson, amyotrophic lateral sclerosis and SLE 64 – 67 .”
BackgroundFibrin aggravates periodontitis through inducing NETs formation from mitochondrial DNA
Chen, Y., Mei, E., Nan, S., Chen, X., Zhang, P., Zhu, Q., Lan, D., Qi, S., & Wang, Y. (2024) · Oral Diseases · doi:10.1111/odi.15073 · Cited by 14
JMJD3 Is Required for Acute Pancreatitis and Pancreatitis-Associated Lung Injury
Chen, L., Zhang, X., Liu, Y., Liu, L., Liang, X., Yang, S., Xia, Q., Jin, T., Ma, Y., Chen, Y., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200484 · Cited by 15
Tang, M., Outissint, I., Chen, Y., & Gong, X. (2025) · Journal of Cellular Biochemistry · doi:10.1002/jcb.70056 · Cited by 16
“Therapeutically, targeting mitochondrial pathways presents a promising strategy to restore immune homeostasis in SLE [141 – 145].”
Role of Neutrophils in Homeostasis and Diseases
Chang, X., Liu, Y., Qiu, J., & Hua, K. (2025) · MedComm · doi:10.1002/mco2.70390 · Cited by 16
“NETs further enhance IFN-I responses by stimulating the cytosolic cyclic GMP–AMP synthase–STING pathway through higher levels of oxidized gene combinations and mitochondrial DNA [44, 335].”
NETosis in ischemic stroke: Mechanisms, implications, and therapeutic prospects
Krishnamoorthy, N., Kalyan, M., Vichitra, C., Paneyala, S., Rashan, L. J., Azeeze, M. S. T. A., Sakharkar, M. K., Chang, S. L., Monaghan, T. M., Mahalakshmi, A. M., et al. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.108999 · Cited by 16
Harsini, S., & Rezaei, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818006-8.00001-3 · Cited by 13
Song, Y., Hussain, T. A., Wang, J., Liao, Y., Yue, R., Sabir, N., Zhao, D., & Zhou, X. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz461 · Cited by 15
Mitochondrial dysfunction and fatigue in Sjögren’s disease
Kurien, B. T., Ice, J. A., Wood, R., Pharaoh, G. A., Cavett, J. W., Lewis, V., Bhaskaran, S., Rasmussen, A., Lessard, C. J., Farris, A. D., et al. (2025) · RMD Open · doi:10.1136/rmdopen-2024-005046 · Cited by 14
Mitochondrial DNA in innate immune responses against infectious diseases
Das, P., & Chakrabarti, O. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200687 · Cited by 12
Prognostic value of circulating mitochondrial DNA in prostate cancer and underlying mechanism
Borah, S., Mishra, R., Dey, S., Suchanti, S., Bhowmick, N. A., Giri, B., & Haldar, S. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.05.005 · Cited by 13
Effect of 8-Hydroxyguanine DNA Glycosylase 1 on the Function of Immune Cells
Zhang, W., Zhong, R., Qu, X., Xiang, Y., & Ji, M. H. (2023) · Antioxidants · doi:10.3390/antiox12061300 · Cited by 13
“In SLE, low-density neutrophils are an important source of oxidized mtDNA, which is released from activated neutrophils upon NET production [50,51].”
BackgroundThe SARS-CoV-2 spike glycoprotein interacts with MAO-B and impairs mitochondrial energetics
Pileggi, C. A., Parmar, G., Elkhatib, H., Stewart, C. M., Alecu, I., Côté, M., Bennett, S. A. L., Sandhu, J. K., Čuperlović‐Culf, M., & Harper, M. (2023) · Current Research in Neurobiology · doi:10.1016/j.crneur.2023.100112 · Cited by 15
“Damaged cells release mtDNA into circulation to activate inflammation and neutrophil recruitment when a cell is unable to complete the removal of dysfunctional mitochondria via mitophagy (Caielli et al., 2016).”
BackgroundChanges of NADH Fluorescence from the Skin of Patients with Systemic Lupus Erythematosus
Bogaczewicz, J., Tokarska, K., & Woźniacka, A. J. (2019) · BioMed Research International · doi:10.1155/2019/5897487 · Cited by 13
“Such a condition could also occur as a result of endothelial dysfunction with links to autoantibodies against double-stranded DNA (dsDNA) and RNA-protein complexes, activation of the type I interferon system, and platelets in SLE patients [18].”
BackgroundInfluentialPrinciples of mitochondrial vesicle transport
McLelland, G., & Fon, E. A. (2018) · Current Opinion in Physiology · doi:10.1016/j.cophys.2018.02.005 · Cited by 13
Fu, J., Liu, Q., Yuan, Y., Li, R., Wang, J., Zhao, Y., Yan, X., & Su, J. (2025) · Cancer Science · doi:10.1111/cas.70172 · Cited by 11
“Among these, breakage and release of mtDNA are thought to characterize dysregulated mitochondrial homeostasis [42, 43].”
Insights into the pathogenesis of childhood-onset SLE in the past decade
Robinson, G., Knight, A., Tucker, L. B., Bélot, A., Isenberg, D. A., & Ciurtin, C. (2025) · Nature Reviews Rheumatology · doi:10.1038/s41584-025-01321-x · Cited by 14
“However, a 2025 study in individuals with childhood-onset SLE found increased levels of anti-mitochondrial autoantibodies that correlated with elevated serum IFNα2 and disease activity 94 , consistent with the role of mitochondria-derived signals in type I IFN production in childhood-onset SLE 95 .”
Carter, L. M., Yusof, M. Y. M., Wigston, Z., Plant, D., Wenlock, S. C., Alase, A. A., Psarras, A., & Vital, E. M. J. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-225349 · Cited by 13
“29 Immune complexes involving ribonucleoprotein are potent induces of mitochondrial ROS and superoxide, 32 leading to loss of mitochondrial membrane potential and extrusion of oxidised mitochondrial DNA (mtDNA) 33 where it is a component of low-density granulocytes NETosis in SLE.”
BackgroundIntersection of the microbiome and immune metabolism in lupus
Garcia, A. C., Six, N., Ma, L., & Morel, L. M. (2024) · Immunological Reviews · doi:10.1111/imr.13360 · Cited by 12
“21 A causal link between gut dysbiosis and lupus pathogenesis through type I IFN induced by mitochondrial metabolism has not been explored yet.”
Keratinocytes – Amplifiers of Immune Responses in Systemic Lupus Erythematosus
Klein, B., Nguyen, N. T., Moallemian, R., & Kahlenberg, J. M. (2024) · Current Rheumatology Reports · doi:10.1007/s11926-024-01168-3 · Cited by 11
Muñoz-Urbano, M., Quintero-González, D. C., & Vásquez, G. M. (2022) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2022.2055568 · Cited by 11
“On the other hand, an in vivo lupus mouse model (MRL/lpr mice) confirmed that mitochondrial ROS inhibition reduces disease severity and attenuates IFN-I responses [77,78].”
BackgroundSuper-resolution imaging for in situ monitoring sub-cellular micro-dynamics of small molecule drug
Chen, H., Fang, G., Ren, Y., Zou, W., Ying, K., Yang, Z., & Chen, Q. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.022 · Cited by 11
“Previous studies have shown that elevated levels of mitochondrial ROS can also damage to mitochondrial DNA (mtDNA) damage 44 .”
BackgroundDrury, B., Chuah, C. S., Hall, R., Hardisty, G. R., Rossi, A. G., & Ho, G. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.03.022 · Cited by 10
“26 There are limitations to our study.”
Rethinking neutrophil extracellular traps
Liu, Y., Ma, Y.-H., Yang, J.-W., Man, J.-W., Wang, H.-B., Li, Y., Liang, C., Cao, J., Chen, S., Li, K.-P., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110834 · Cited by 13
The influence and therapeutic effect of microbiota in systemic lupus erythematosus
Mo, C., Bi, J., Li, S., Lin, Y., Yuan, P., Liu, Z., Jia, B., & Xu, S. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127613 · Cited by 12
Myeloid cells as IFNα producers in systemic lupus erythematosus
Kuga, T., Chiba, A., Murayama, G., & Miyake, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1562221 · Cited by 10
“In SLE, nucleic acids derived from apoptotic cells, those contained in neutrophil extracellular traps (NETs) and mitochondrial DNA released due to mitochondrial stress have been demonstrated to activate nucleic acid receptor pathways (9 – 11).”
Dual Nature of Neutrophil Extracellular Traps (NETs)—From Cancer’s Ally to Therapeutic Target
Buszka, K., Dompé, C., Derwich, K., Pieścikowska, I., Nowicki, M. O., & Budna, J. (2025) · Cells · doi:10.3390/cells14151200 · Cited by 13
“Subsequent research has identified a wide array of NET-inducing stimuli, including lipopolysaccharides, GM-CSF/C5a and IFN-α /IFN-γ /C5a [29,32–35].”
Zhang, Q., Chen, L., Liu, J.-Y., Liu, T., Wang, R., Wu, X., & Li, S. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07302-8 · Cited by 12
“Recent studies demonstrate Ox-mtDNA’s critical role in various pathologies, including metabolic diseases (e.g., MASH) [23], autoimmune disorders, and neurodegenerative diseases [24, 25].”
Gómez-Bañuelos, E., Wahadat, M. J., Li, J., Paz, M., Antiochos, B., Celia, A. I., Andrade, V., Ferris, D. P., GOLDMAN, D. W., Darrah, E., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.163795 · Cited by 10
“4 plasmacytoid dendritic cells (16-20), it is noteworthy that neutrophils are also important targets of IFN-I in this disease (16), suggesting the possibility that these cells may be an important source of autoantigens induced by IFN in SLE.”
BackgroundMalkiel, S., & Diamond, B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801917-7.00024-3 · Cited by 10
Editorial: The Innate and Adaptive Immune Response Are Both Involved in Drug‐Induced Autoimmunity
Sawalha, A. H. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40371 · Cited by 9
“All rights reserved extruded within NETs has been recently shown to be a potent interferogenic DNA enhancing neutrophil-dependent type I interferon production in lupus (16-18).”
BackgroundMitochondrial motility modulators coordinate quality control dynamics to promote neuronal health
Jenkins, J. E., Fazli, M., & Evans, C. S. (2024) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2024.102383 · Cited by 9
Mitochondrial DNA: leakage, recognition and associated human diseases
Takamatsu, H. (2025) · The Journal of Biochemistry · doi:10.1093/jb/mvaf037 · Cited by 10
The Pathophysiological Role of Mitochondrial Oxidative Stress in Rheumatic Diseases
Ma, Z., Xu, Q., & Xu, X. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s534574 · Cited by 14
“73 Consequently, PINK1/Parkin dysfunction and its oxidative stress-inflammation axis are increasingly implicated in chronic inflammatory disorders including rheumatic diseases.”
Unveiling Leukocyte Extracellular Traps in Inflammatory Responses of the Central Nervous System
Colciaghi, F., & Costanza, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.915392 · Cited by 11
“Moreover, low-density gradient neutrophils, a cell subset identified in SLE patients (45), spontaneously release NETs enriched in oxidized mtDNA compared to NETs from normal-density gradient neutrophils of healthy controls (44).”
BackgroundInfluentialMitochondrial DNA: a novel indicator of active inflammation in ANCA-associated vasculitides
Giaglis, S., Daoudlarian, D., Thiel, J., Rizzi, M., Kyburz, D., Venhoff, N., & Walker, U. A. (2023) · Rheumatology · doi:10.1093/rheumatology/kead015 · Cited by 10
“…, 2023, 62 , 2930–2937 https://doi.org/10.1093/rheumatology/kead015 Advanceaccesspublication16January2023 Original article Rheumatology [11–13]. mtDNA released by neutrophils in AAV could therefore be particularly well suited to promote disease flares and systemic immune-mediated organ…”
InfluentialTew, D. J., Hebert, J. M., & Schmier, B. J. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102658 · Cited by 9
Lai, J., Wu, D., Huang, C., Hung, L., Wu, C., Ka, S., Chen, A., Huang, J., & Ho, L. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02140-z · Cited by 10
“…from engulfed red blood cells by monocytes/macrophages or from neutrophil extracellular traps also serves as a potent inducer of IFN signaling through activating toll-like receptor (TLR) − 9 and the cyclic GMP-AMP synthase (cGAS)- stimulator of interferon genes (STING) signaling pathway [13, 14].”
Erythrocyte-derived mitochondria: an unexpected interferon inducer in lupus
Morel, L. M. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.10.010 · Cited by 9
Caielli, S., Athale, S., Domic, B., Murat, E., Chandra, M., Banchereau, R., Baisch, J. M., Phelps, K., Clayton, S., Gong, M., et al. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.2132oia85 · Cited by 9
Self-citationMicroparticles - culprits in the pathogenesis of systemic lupus erythematosus?
Rasmussen, N. S., & Jacobsen, S. (2018) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2018.1474100 · Cited by 9
Mechanisms and effects of activation of innate immunity by mitochondrial nucleic acids
Rai, P., & Fessler, M. B. (2024) · International Immunology · doi:10.1093/intimm/dxae052 · Cited by 12
Mitochondria as Inducers of Neutrophil Extracellular Traps
Bečka, E., Hudecová, L., & Pastorek, M. (2026) · Inflammation · doi:10.1007/s10753-025-02432-z · Cited by 10
“Pathologically, dysfunctional TFAM phosphorylation in conditions like systemic lupus erythematosus can lead to retention of oxidized mtDNA nucleoids within mitochondria and their subsequent extrusion as interfero-genic complexes [72].”
Sanz, I. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40109 · Cited by 8
“Phenotype and function of pathogenic and regulatory cells B cells and plasma cells (13,53–58) T cells (59–62) Myeloid cells (28,57,63–67) Understanding disease progression Early events leading to disease development (22,68) Mechanisms of end-organ damage and repair (28) In situ adaptive and innate immune reactions in…”
Chua, A. W. C., Guo, D., Tan, J. C., Lim, F. T. W., Ong, C. T., Masilamani, J., Lim, T. K. H., Hwang, W. Y. K., Lim, I. J., Chen, J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010365 · Cited by 8
“demonstrated that netting neutrophils stimulated plasmacytoid dendritic cells (pDCs) to secret type I IFN directly [3] and further promoted the expansion of plasmablasts indirectly [4,5], suggesting the upstream effects of neutrophils in the pathogenesis of SLE.”
Mitochondrial damage‐associated molecular patterns in blood transfusion products
Marcoux, G., & Boilard, É. (2017) · ISBT Science Series · doi:10.1111/voxs.12381 · Cited by 10
Puyo, C. A., Earhart, A., Staten, N. R., Huang, Y., Desai, A. C., Lai, H. H., & Venkatesh, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-24818-w · Cited by 8
Luo, J., Liu, H., Li, D. K. J., Song, B., & Zhang, Y. (2021) · BMC Immunology · doi:10.1186/s12865-021-00464-2 · Cited by 8
Molecular and Inflammatory Etiologies of β-Cell Dysfunction in Type 1 Diabetes
Rostron, C. R., & Evans‐Molina, C. (2025) · Physiology · doi:10.1152/physiol.00008.2025 · Cited by 10
Morgan, H., Little, K., Dutta, S., Chen, S., Gong, J., Koduri, S., Raja, A., Lin, W., Saini, K., Bhullar, R., et al. (2025) · Cells · doi:10.3390/cells15010033 · Cited by 12
“Both forms of NETosis release substantial amounts of extracellular cfNAs, including cfDNA [115–117] and cf-mtDNA [118], which have been implicated in systemic immune dysregulation in disease [119].”
Ghosh, A. R., Bandopadhyay, P., Sarkar, J., Khanna, S., Chaudhuri, T., Tantia, O., Chakrabarti, P., & Ganguly, D. (2023) · Obesity · doi:10.1002/oby.23805 · Cited by 7
“On the other hand, in some clinical contexts, the TLR9 activating molecules are frequently reacted against as autoantigens by primed adaptive immune cells, e.g., anti-DNA antibodies in SLE, the cathelicidin antimicrobial peptide LL-37 in psoriasis [11, 13].”
BackgroundInfluentialVeldkamp, S. R., van Wijk, F., van Royen‐Kerkhof, A., & Jansen, M. H. A. (2024) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2024.101976 · Cited by 8
Emerging areas for therapeutic discovery in SLE
Maria, N. I., & Davidson, A. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.09.004 · Cited by 8
“Both TLR9 and STING have been implicated in recognition of neutrophil derived oxidized mitochondrial DNA [15,16].”
BackgroundImplication of a lysosomal antigen in the pathogenesis of lupus erythematosus
Wilhelm, M., Bonam, S. R., Schall, N., Bendorius, M., Korganow, A., Lumbroso, C., & Muller, S. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102633 · Cited by 10
The role of mitochondria in immune-mediated disease: the dangers of a split personality
Pisetsky, D. S. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1063-5 · Cited by 7
Chowdhury, C. S., Kinsella, R. L., Nehls, E. M., Naik, S. K., Lane, D. S., Talukdar, P., Chavez, S. M., Smirnov, A., Beatty, W. L., Kreamalmeyer, D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.29.518376 · Cited by 10
Zhao, G., Li, H., Miao, Y., Cheng, L., Chen, Y., Huang, Y., Zhao, H., Liu, Y., Jing, Y., Wang, S., et al. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1585847 · Cited by 7
Liu, Y., Ma, X., Guan, Q., & Zhou, S. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1774015 · Cited by 7
Miro-mediated mitochondrial transport: A new dimension for disease-related abnormal cell metabolism?
Li, Y., Yang, Z., Zhang, S., & Li, J. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149737 · Cited by 9
Anti-TFAM antibodies link mitochondrial damage with antiphospholipid syndrome and thrombosis in SLE
Gómez-Bañuelos, E., Celia, A. I., Trejo‐Zambrano, M. I., Anda, J.-A. R.-D., Paz, M., Chaturvedi, S., Conti, F., Alessandri, C., Tiniakou, E., GOLDMAN, D. W., et al. (2025) · Annals of the Rheumatic Diseases · doi:10.1016/j.ard.2025.04.015 · Cited by 6
Zhang, H., Li, J.-Y., Wang, C., & Zhong, G. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i2.342 · Cited by 6
Hegde, M., Girisa, S., Devanarayanan, T. N., Alqahtani, M. S., Abbas, M. A. E., Sethi, G., & Kunnumakkara, A. B. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0329 · Cited by 6
“In addition, NETs formed in SLE models were found to be mtROS-dependent, which is an unusual mechanism compared with regularly reported NOX-dependent cytosolic ROS (Caielli et al., 2016; Lood et al., 2016).”
InfluentialMonogenic lupus – from gene to targeted therapy
Menzel, K., Novotná, K., Jeyakumar, N., Wolf, C., & Lee‐Kirsch, M. A. (2024) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-024-00181-x · Cited by 8
“The DNA substrate for DNase I can come from a variety of sources, including extracellular DNA waste derived from dying cells or immune complexes and oxidized mitochondrial DNA contained in neutrophil extracellular traps [11].”
BackgroundScreening for Mitochondrial tRNA Variants in 200 Patients with Systemic Lupus Erythematosus
Xuan, D., Qiang, F., Xu, H., Wang, L., & Xia, Y. (2024) · Human Heredity · doi:10.1159/000542357 · Cited by 5
“In addition to genetic and environmental factors, mitochondrial dysfunction can also be involved [36]. mtDNA is a multi-copy, circular, double-stranded DNA molecule that is essential for OXPHOS.”
Recent insights into the role of innate immunity in lupus
Robinson, L. A., & Pascual, V. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddaf066 · Cited by 7
“Platelet-intrinsic TLR7 activation also promotes formation of platelet–neutrophil complexes and enhances neutrophil extracellular trap formation (NETosis) [61], a pathway linked to SLE pathogenesis [62–64].”
Self-citationMitochondrial DNA may act as a biomarker to predict donor‐kidney quality
Hao, C., Zhang, J., Zhang, F., Wu, J., Cao, H., & Wang, W. (2021) · Clinical Transplantation · doi:10.1111/ctr.14469 · Cited by 5
Ahmad, A. H., Melbouci, D., & Decker, P. (2022) · Immuno · doi:10.3390/immuno2010007 · Cited by 8
“In addition, lupus PMNs extrude oxidized mitochondrial DNA-protein complexes and these complexes are interferogenic, as they stimulate plasmacytoid DC (pDC) to secrete IFN-α [90], a key lupus cytokine.”
BackgroundCanugovi, C., Stevenson, M., Vendrov, A. E., Lozhkin, A. P., Britton, S. L., Koch, L. G., Runge, M. S., & Madamanchi, N. R. (2022) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2022.35 · Cited by 5
Günther, C., & Wenzel, J. (2023) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.15049 · Cited by 5
The Role of Microparticles in Rheumatic Diseases and their Potentials as Therapeutic Tools.
Shao, W.-H. (2016) · PubMed · Cited by 5
An unconventional mechanism of IL-1β secretion that requires Type I IFN in lupus monocytesPreprint
Caielli, S., Balasubramanian, P., Rodríguez-Alcázar, J. F., Balaji, U., Wan, Z., Baisch, J. M., Smitherman, C., Walters, L., Sparagana, P. R., Nehar-Belaid, D., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.03.551696 · Cited by 6
Self-citationGuo, C., Lei, Z., Zhao, L., & Wei, P. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104029 · Cited by 6
Zhang, S., Hu, W., Tang, Y., & Chen, X. (2025) · PLoS ONE · doi:10.1371/journal.pone.0318280 · Cited by 4
The Role of Dendritic Cells in Systemic Lupus Erythematosus
Jacquemin, C., & Blanco, P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801917-7.00016-4 · Cited by 4
Neutrophils in Systemic Lupus Erythematosus
Sawalha, A. H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801917-7.00015-2 · Cited by 5
Нестерова, И. В. (2017) · CHILDREN INFECTIONS · doi:10.22627/2072-8107-2017-16-2-50-53 · Cited by 4
The Innate Immune System in SLE
Elkon, K. B., & Lood, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47927-1.00008-6 · Cited by 4
Becker, Y. L. C., Boilard, É., Rollet-Labelle, E., Lood, C., Julien, A.-S., Abrahamowicz, M., Allaeys, I., Choi, M., Leclerc, J., Lévesque, T., et al. (2026) · Annals of the Rheumatic Diseases · doi:10.1016/j.ard.2025.11.007 · Cited by 3
Pan, Q., Huang, X., Liu, C., Pan, Q., & Huang, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1492726 · Cited by 6
β2-glycoprotein I promotes the clearance of circulating mitochondria
Dasgupta, S. K., Gollamudi, J., Rivera, S., Poché, R. A., Rumbaut, R. E., & Thiagarajan, P. (2024) · PLoS ONE · doi:10.1371/journal.pone.0293304 · Cited by 4
Metabolic control of pathogenesis in autoimmune diseases
Perl, A., & Morel, L. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00059-x · Cited by 4
Romana, M., Laurance, S., Hardy‐Dessources, M., Claër, L., Ravion, S., Dorgham, K., Garnier, Y., Kuznicki, L., Tarer, V., Tressières, B., et al. (2024) · HemaSphere · doi:10.1002/hem3.70030 · Cited by 3
“19 Overall, our current study strongly reinforces the concept of an abnormal mitochondria retention in SS and more surprisingly in SC patients, and finely characterizes the erythroid population that retained mitochondria.”
Background
Metadata
- Authors
- Caielli, S., Athale, S., Domic, B., Murat, E., Chandra, M., Banchereau, R., Baisch, J., Phelps, K., Clayton, S., Gong, M., Wright, T., Punaro, M., Palucka, K., Guiducci, C., Banchereau, J., & Pascual, V.
- Affiliations
- Baylor Institute for Immunology Research, Dallas, TX 75204 1
- The University of Texas Southwestern Medical Center (US)
- Dynavax Technologies (United States) (US)
- Texas Scottish Rite Hospital for Children (US)
- The Jackson Laboratory for Genomic Medicine (US)
- Corresponding author
- Pascual, Virginia
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2016-04-18
- Volume
- 213
- Issue
- 5
- Pages
- 697-713
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC4854735
- OpenAlex
- W2338241371
- Cited by
- 501
- References
- 52
- Citations by year
- 2026: 41 · 2025: 46 · 2024: 64 · 2023: 64 · 2022: 55 · 2021: 44 · 2020: 42 · 2019: 45 · 2018: 49 · 2017: 33 · 2016: 17
- FWCI
- 51.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- Funders
- National Institutes of Health (P50 AR054083-01, U19 AI082715)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- systemic lupus erythematosus, type I interferon, neutrophils, mitochondrial DNA, mitochondrial nucleoids, mitophagy, autoantibodies, lysosomal degradation, autoinflammation, therapeutic target
- MeSH terms
- Adolescent, Autoantibodies, Child, Child, Preschool, DNA-Binding Proteins, DNA, Mitochondrial, Female, Humans, Interferon Type I, Lupus Erythematosus, Systemic, Male, Mitochondria, Neutrophils, Oxidation-Reduction, Transcription Factors, Mitochondrial Proteins, Toll-Like Receptor 7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.